Tirzepatide Vs Semaglutide Comparison
Tirzepatide and semaglutide operate through distinct molecular mechanisms, with tirzepatide functioning as a dual GIP/GLP-1 receptor agonist while semaglutide selectively targets GLP-1 receptors. Both medications require weekly subcutaneous administration with gradual dose escalation, though tirzepatide shows slightly higher gastrointestinal side effects. Their divergent receptor activation patterns and pharmacodynamic properties explain the observed differences in clinical outcomes and therapeutic potential. Further analysis reveals…